Bay Labs Announces Collaboration with Edwards Lifesciences to Utilize AI Software to Improve Heart Disease Detection
12/10/18: The partnership involves multiple initiatives, including the development of new AI-powered algorithms in Bay Labs’ EchoMD measurement and interpretation software suite, the integration of EchoMD algorithms into Edwards Lifesciences’ CardioCare quality care navigation platform, and support for ongoing clinical studies at leading institutions.
New Study Demonstrates Accuracy of Fully-Automated Ejection Fraction Calculation Using Bay Labs’ EchoMD AutoEF Software
6/25/18: “Historically there have been challenges with variability and reproducibility in reporting of the ejection fraction, especially when the EF is not normal; our study showed that the EchoMD AutoEF algorithms can aid interpretation enormously and have less variability than cardiologists reported in literature,” said Richard Bae, MD, FACC, Director of the Echocardiography Laboratory at the Minneapolis Heart Institute and co-author of the study. “By supporting fast, efficient and accurate AI-assisted echocardiogram analysis, the algorithms can allow physicians to focus on putting results into context for the patient - guiding prognosis and course of management.”
Bay Labs Receives FDA Clearance for AI Algorithms Fully Automating Cardiac Ultrasound Analysis to Detect Heart Disease
6/19/18: With this recent clearance, Bay Labs will make EchoMD AutoEF available to cardiologists to support fast, efficient and accurate AI-assisted echocardiogram analysis and ensure the highest quality care for their patients.